The genotyping of human leukocyte antigens C (HLA-C) in psoriasis patients.

Authors

  • Rana Ahmad Tishreen University
  • Haissam Yazigi Tishreen University
  • Faisal Redwan Tishreen University
  • Fouz Hassan Tishreen University

Abstract

Background: Psoriasis is a complex skin disease with a genetic immunological background, with the dominance of MHC region genes as one of a group of factors that intervene in the pathogenetic mechanism and predict therapeutic response.

Aim: To identify human leukocyte antigen C alleles in psoriasis patients compared to healthy individuals.

Materials and Methods: Fifty psoriasis patients with or without arthritis were compared with thirty people without psoriasis and without a family history of psoriasis. They were randomly selected and considered as controls. Their HLA-C alleles were determined by PCR-SSP.

Results: Out of 50 chronic psoriasis patients; the number was 13 male patients (26%) and 37 female patients (74%), with the average age of the patients being 40.42±17.62 years. There were 30 control cases, including 12 male patients (40%) and 18 female patients (60%), with an average age of 40.42 ± 17.62 years. A positive family history was recorded in 18.7% of the patients. 74% of psoriasis cases were of the early type, with a mean age of disease onset of 29.04±15.6 years. The most common clinical phenotype was plaque psoriasis diagnosed in 80% of cases, followed by pustular psoriasis and guttate psoriasis; 12% and 8%, respectively. 24 of 50 patients (48%) had mild disease according to the PASI score. The HLA-C*06 allele was more common in psoriasis patients compared to the control group (42% in the patients' group, 16.7% in the control group with a statistically significant difference (p-value = 0.02), with a higher risk of developing psoriasis (odds ratios OR [CI95%] = 3.6[1.1-11.01]), while *03 was considered a protective allele against psoriasis.

Conclusion: The importance of the HLA-C*06 allele as a primary risk factor for psoriasis in the Syrian population has been noted. Therefore, early genotyping of patients’ first- or second-degree relatives is recommended to detect its presence in them and apply preventive measures that limit the early appearance of the disease.

Downloads

Published

2024-08-22

How to Cite

1.
احمد ر, هيثم يازجي, فيصل رضوان, فوز حسن. The genotyping of human leukocyte antigens C (HLA-C) in psoriasis patients. . Tuj-hlth [Internet]. 2024Aug.22 [cited 2024Sep.1];46(3):205-1. Available from: https://journal.tishreen.edu.sy/index.php/hlthscnc/article/view/17003

Issue

Vol. 46 No. 3 (2024): Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

 Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series   .  The Readers have the right to send, print and subscribe to the initial version of the article, and the title of  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series  Publisher

journal uses a CC BY-NC-SA license which mean

You are free to:

  • Adapt — remix, transform, and build upon the material
  •  
  • The licensor cannot revoke these freedoms as long as you follow the license terms.

 

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Most read articles by the same author(s)